Nervgen Pharma Corp (NGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2008 | 12-2007 | 12-2006 | |
| Gross Profit | N/A | N/A | 29,570 | 13,880 | 13,560 |
| Operating Expenses | 17,949 | 18,195 | 18,650 | 26,460 | 25,680 |
| Operating Income | -17,949 | -18,195 | -18,650 | -26,460 | -25,680 |
| Other Income | -13,626 | 676 | 0 | 0 | 0 |
| Pre-tax Income | -31,575 | -17,520 | -18,650 | -26,460 | -25,680 |
| Net Income Continuous | -31,575 | -17,520 | -18,650 | -26,460 | -25,680 |
| Net Income | $-31,575 | $-17,520 | $-18,650 | $-26,460 | $-25,680 |
| EPS Basic Total Ops | -0.44 | -0.26 | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -0.44 | -0.26 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.44 | -0.26 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -0.44 | -0.26 | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | N/A | N/A | -0.29 | -0.55 | -0.78 |
| EBITDA(a) | $-17,909 | $-18,134 | $-18,650 | $-18,190 | $-19,010 |